QMA

Alkermes plc (ALKS) — QMA analysis

Sector: Healthcare · Market cap: $5.7B · Price: $43.63 · Data as of 2026-10-23

45
/100
D
Composite grade
Higher score than 54% of 22,734 tracked stocks

Alkermes plc has a below-average composite score of 45/100, higher score than 54% of 22,734 tracked stocks. The highest-scoring layer is Fundamental value; the lowest is Insider activity.

Analytical score, not investment advice. No score is an instruction or a guarantee. Past performance ≠ future results.

What 6 data layers say about ALKS

The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.

LayerScore
Fundamental value (FVS)69/100
Technical trend (TSS)41/100
Relative strength (RS)33/100
Momentum (USS)36/100
Insider activity (IAS)10/100
Off-exchange trading (FINRA) / large flows (WHS)42/100

What does the QMA model currently show for Alkermes plc?

The composite score is a research starting point, not an instruction. What matters is layer confluence — whether the layers point in the same direction.

For ALKS the layers diverge — some score high (Fundamental value), others low (Insider activity). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.

ALKS insider & smart money activity

Over the recent period we record 8 reported insider purchases and 16 sales for ALKS: mixed picture. A description of the data layer, not an instruction.

ALKS seasonality

The historically strong window for ALKS was January 1–28 with a hit rate of 75% and an average move of 4.4% (21 years of history).

Historical data does not guarantee future results.

How ALKS compares

Similar stocks from the same sector:

Frequently asked questions

What is the composite score for ALKS stock?

45/100 (D) — Data as of 2026-10-23.

Are insiders buying ALKS stock?

Over the recent period, reported: purchases 8, sales 16 (purchases $13.2M, sales $5.36M). Insider activity: mixed picture — a description of reported data, not a trade instruction.

Where can I see live ALKS data?

Live ALKS data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.

Free registration, no card — trial full access, then the free plan

Open ALKS detail →

Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.

⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.

Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]